James Peterson, MD
Obstetrics · Salt Lake City, UTNPI 1316962442
Payments from drug & device makers
Across 2,972 payments — averaging $6856.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$11.9M
- Modernatx, Inc.$6.2M
- Sanofi Pasteur Inc.$1.4M
- Ipsen Innovation$365K
- Merck$273K
- GSK$101K
- plus $207K from 54 others
Across 26 payments — averaging $1179.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$23K
- Sanofi Pasteur Inc.$8K
- Sanofi US Services Inc.$55
What the payments were for
- Consulting fees$1,20011%
- Travel & lodging$9869%
- Food & beverage$8,67080%
- Education$110%
- Gifts$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$1,200
- V114$865
- VIVITROL$115
- VOQUEZNA$112
- APRETUDE$105
How this compares
Too few obstetrics providers in Utahto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 49 | $59,639 |
| EliquisApixaban | 38 | $54,025 |
| MounjaroTirzepatide | 41 | $46,377 |
| JardianceEmpagliflozin | 24 | $35,278 |
| OzempicSemaglutide | 12 | $15,340 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $7,996 |
| Atorvastatin Calcium | 450 | $4,813 |
| Metformin Hcl ErMetformin Hcl | 185 | $3,296 |
| Gabapentin | 139 | $3,278 |
| Levothyroxine Sodium | 276 | $2,826 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $2,491 |
| Rosuvastatin Calcium | 193 | $2,143 |
| Duloxetine Hcl | 51 | $1,982 |
| Novolog FlexpenInsulin Aspart | 14 | $1,887 |
| Bupropion XlBupropion Hcl | 52 | $1,877 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $257 | $59,63949 claims |
| PfizerEliquis | $11,922,198 | $54,02538 claims |
| Lilly USA, LLCMounjaro | $476 | $46,37741 claims |
| Boehringer IngelheimJardiance | $550 | $35,27824 claims |
| Novo NordiskOzempic | $243 | $15,34012 claims |
| GSKTrelegy Ellipta | $101,293 | $7,99612 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $17 | $2,826276 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few obstetrics providers in Utahon file to place this against a meaningful peer group, so we don't.
Other obstetrics in Salt Lake City
- Shane ChristensenSalt Lake City$24.7M
- Gayle StewartSalt Lake City$5K
- Thomas ConnerSalt Lake City$3K
- Natalie LoewenSalt Lake City$46
- Cynthia JonesSalt Lake City$18
- Layne SmithDraper$8K
- Cameron LeavittSt George$3K
- Robert LaterSandy$2K
- Chad LuntSt George$2K
- Douglas AllenPleasant Grove$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.